Has Eugene Lin, MD received payments from drug or device companies?

Yes. Drug and device makers reported $18,641 in general payments to Eugene Lin, MD across 319 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Eugene Lin, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Eugene Lin, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Eugene Lin, MD

Vascular Neurology · Toledo, OHNPI 1619137965

Payments from drug & device makers

What this record shows

41 manufacturers reported payments, led by Rapid Medical Ltd at 38.0% of the total. Reporting peaked in 2019 at $8,925 and has fallen 64.6% since, to $3,162 in 2025.

$18,641in general payments, 2019–2025

Across 319 payments — averaging $58.44 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Rapid Medical Ltd$7K
Johnson & Johnson$2K
Stryker$2K
Imperative Care, Inc$2K
Route 92 Medical, Inc.$1K
Microvention, Inc.$878
plus $4K from 35 others

$110,243in research payments, 2019–2025

Across 37 payments — averaging $2979.54 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Medical Device Business Services, Inc.$110K

What the payments were for

Travel & lodging$7,60841%
Food & beverage$11,03359%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Rapid Medical Ltd	6	$7,076
Johnson & Johnson(3 entities)	83	$2,215
Stryker	43	$1,718
Imperative Care, Inc	38	$1,658
Route 92 Medical, Inc.	3	$1,063
Microvention, Inc.	7	$878
Penumbra, Inc.	32	$801
Medtronic(2 entities)	29	$546
Qapel Medical Inc	2	$327
AstraZeneca(2 entities)	5	$281
Viz.ai, Inc.	1	$198
Scientia Vascular	1	$170
Medical Device Business Services, Inc.	3	$165
Asahi Intecc USA, Inc.	4	$135
Abbott	7	$129
Argenx US, Inc.	2	$128
Janssen Scientific Affairs, LLC	1	$122
UCB, Inc.	3	$119
Integra Lifesciences Corporation	6	$110
Nevro Corp.	4	$84
Aesculap, Inc.	5	$78
AbbVie	3	$65
Chiesi USA, Inc.	3	$60
Terumo Medical Corporation	3	$57
Arbor Pharmaceuticals, Inc.	2	$48
Portola Pharmaceuticals, LLC	2	$46
Azurity Pharmaceuticals, Inc.	3	$45
Cardiva Medical, Inc.	2	$43
Avanir Pharmaceuticals, Inc.	2	$37
Angiodynamics, Inc.	2	$29
Cardinal Health 200 LLC	1	$26
Novartis	1	$23
Orthofix Medical, Inc.	2	$21
Bayer	1	$21
Avanos Medical	1	$20
Sirtex Medical Inc	1	$20
Si-bone, Inc.	1	$18
Biohaven Pharmaceutical Holding Company Ltd.	1	$18
CSL Behring	1	$16
Lilly USA, LLC	1	$13
Genentech USA, Inc.	1	$13

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

Comaneci$6,839
WEB$734
ZOOM 88-T LARGE DISTAL PLATFORM$458
8F Base Camp Sheath System$425
TARGET$262
XARELTO$246
088 Access System$233
Embotrap$211
Viz.AI LVO$198
RED 72$134
TIGERTRIEVER 17 REVASCULARIZATION DEVICE$127
COMANECI 17$127
AXS VECTA 71$121
Pipeline$117
BROADWAY 8$113
ANDEXXA$112
SURPASS EVOLVE$110
EMBOGUARD$102
Penumbra Coil 400$101

How this compares

$18,641 in reported general payments places this provider in the 80th percentile of 43 vascular neurology providers in Ohio.

See all vascular neurology providers in Ohio →

Medicare billing

Part B allowed, 2024

$133,531

Medicare patients

366

Services billed

735

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
EliquisApixaban	14	$11,100
Rosuvastatin Calcium	13	$552
ClopidogrelClopidogrel Bisulfate	37	$334
Topiramate	15	$64

Paid to pharmacies, not to this prescriber.

Other vascular neurology in Toledo

Osama ZaidatToledo$844K
Syed ZaidiToledo$26K
Nicholas LiawToledo$6K
Vieh KungToledo$5K
Richard BurgessToledo$4K
Aixa Espinosa-MoralesToledo$177
Muhammad HussainCleveland$105K
Matthew FlahertyCincinnati$71K
Gabor TothCleveland$34K
Brian KatzColumbus$30K

See the full list for Ohio →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →